Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
about
What do we currently know about metabolic syndrome and atrial fibrillation?Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisitedCardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskThe association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients.Meal-related increases in microvascular vasomotion are impaired in obese individuals: a potential mechanism in the pathogenesis of obesity-related insulin resistance.Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese.Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionObesity and atrial fibrillation.Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Insulin resistance is an important risk factor for cognitive impairment in elderly patients with primary hypertensionClinical utility of valsartan in the treatment of hypertension in children and adolescentsThe influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men.Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.Vitamin D and the vascular sensitivity to angiotensin II in obese Caucasians with hypertension.Several lipid-related gene polymorphisms interact with overweight/obesity to modulate blood pressure levels.Relationship between nocturnal blood pressure and 24-h urinary sodium excretion in a rural population in Korea.Sympathoexcitation associated with Renin-Angiotensin system in metabolic syndrome.The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study.Inverse association of long-acting natriuretic peptide with metabolic syndrome in congestive heart failure patientsAldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-UpChinese herbal medicine for the treatment of obesity-related hypertension.Canonical transient receptor potential channels expression is elevated in a porcine model of metabolic syndromePrevalence of Pre-Diabetes and Its Associated Risk Factors in Rural Areas of Ningbo, China.Adipose tissue (P)RR regulates insulin sensitivity, fat mass and body weight.Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes.Metabolic syndrome and cardiometabolic risk: an update.N-terminal pro-B-type natriuretic peptide level inversely associates with metabolic syndrome in elderly persons.Reduction of plasma aldosterone and arterial stiffness in obese pre- and stage1 hypertensive subjects after aerobic exercise.Aging and hypertension.Angiotensin inhibition and longevity: a question of hydration.The paradox of low BNP levels in obesity.Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.Obesity-related hypertension.Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.Beyond salt: lifestyle modifications and blood pressure.Neuro-endocrine regulation of blood pressure.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment--a position paper of the The Obesity Society and The American Society of Hypertension.Rational use of antihypertensive medications in children.Hypertensive heart disease and obesity: a complex interaction between hemodynamic and not hemodynamic factors.
P2860
Q26864437-88F7CA50-8A25-46DB-9FEA-392B8948374EQ28083698-BA387946-8194-4255-8D2B-4E839A8D7B82Q33715302-2C52B7F6-7040-4AD7-9E82-9EBA7D34F53DQ33815592-249F7386-DE1C-4879-B570-0FB9D030A3E4Q33883164-9D574709-E166-488D-91CA-DAE953065ACEQ34012227-1428B7B3-ABB1-458E-BE2E-C544E235281EQ34239668-454ABBB1-311C-4A8E-983D-D95592F03686Q34359362-D1A4DFF5-7083-48AE-B7BF-6A2A98E0236AQ34714245-7F3CE682-9475-4246-BAA8-3368762E8D62Q34774261-ED5D93E7-1419-4ECF-B868-E0C2F8722385Q34957546-A5D98117-1A1A-4F29-81DD-E1D5A02F4080Q35013570-D0BD1D30-24CC-4F97-9AC9-8C5A268E7B4CQ35113885-65982DAF-EBC5-4A2A-9E4E-AA7BFFBA695AQ35137622-5F13ED53-BD2D-43A6-B910-B188928E791AQ36321901-5840F6A1-6587-4237-9D81-00E1C5AD8AC6Q36606501-73964CC2-CB98-4AB1-9A82-734CDED01F8EQ36651383-DC26820D-DAF7-48C2-84E3-3AA94B963891Q36769441-E55CB6C4-341D-49F2-BA06-82C9E7560F68Q36794070-C158EDB7-08FF-4DE6-B39B-B9BC64C13907Q36836343-32E605D5-9D4F-43AE-A301-0EEE6F6F3934Q36988326-AD3A7A98-28C6-497C-AE9B-B9CEEEDB84CAQ37176258-947F32E0-1485-45CB-9FA7-AA390036E877Q37203001-B8096A60-FF2B-4D5D-B1E2-4D90379E5E75Q37279023-78B4526A-910C-49A3-B1F1-29AF6D0D6636Q37345511-B168CBC4-487C-4DC0-A3BB-4733961E53F5Q37370043-E33E2BBD-64FF-40D6-A4DA-6FCCFDAA442EQ37583858-E5D59CE3-079D-48E4-B6F7-6B2367E2FEA3Q37700285-C23BF97B-71C1-42F5-9769-9426845FB3C7Q37810906-F51CF0CE-72C5-47E5-B884-8FD9DDD7B5D7Q37821796-50647675-1D3A-4736-ADE6-CC145CBDF389Q37869374-EA6F6436-BCAB-47AA-B712-A3FCFA9D01A3Q37873230-CD0F34E5-9681-4417-9163-A342EF9904B3Q37878315-F76E0771-180B-4623-AEC5-07FF85A92FF1Q37924914-89398313-B787-483C-B766-375F7C881AFFQ37944603-544FDDB9-4E61-45AE-A21F-F0B366C60458Q37965174-D92922DF-86A0-4D74-8B0F-11177D5061C5Q38071133-73116992-5ADA-4BAB-AE5D-ED34614C69F5Q38080812-3EC8B339-F250-49FC-B505-B4A1DA5E0FE6Q38110184-9DC10C38-659E-496D-950C-997176F752FAQ38211377-1F994DBC-B589-4A8A-903B-54803514F03A
P2860
Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Renin-angiotensin system, natr ...... an integrated view in humans.
@ast
Renin-angiotensin system, natr ...... an integrated view in humans.
@en
type
label
Renin-angiotensin system, natr ...... an integrated view in humans.
@ast
Renin-angiotensin system, natr ...... an integrated view in humans.
@en
prefLabel
Renin-angiotensin system, natr ...... an integrated view in humans.
@ast
Renin-angiotensin system, natr ...... an integrated view in humans.
@en
P2093
P921
P1476
Renin-angiotensin system, natr ...... an integrated view in humans.
@en
P2093
Alessandro Rappelli
Paolo Dessì-Fulgheri
Riccardo Sarzani
P304
P356
10.1097/HJH.0B013E3282F624A0
P50
P577
2008-05-01T00:00:00Z